(1) The Facility shall develop and implement a plan for continuous quality improvement. At a minimum, the plan shall include:
- (a) Structured assessment of the program which addresses Facility program management, staffing, policies and procedures, and general operations;
- (b) A service delivery assessment which, at a minimum, shall evaluate the appropriateness of the ITP development and clinical services delivered, completeness of documentation in service recipients’ medical records, and the quality of and participation in staff training programs, linkage to other community healthcare services, and availability of services and medications for other conditions (e.g. prenatal, tuberculosis, HIV); OPIOD TREATMENT PROGRAM FACILITIES
- (c) An assessment of the aggregate cost of services per service recipient per week for services rendered; and
- (d) An assessment of medication-related issues including take-home procedures, security, inventory and dosage issues.
- (2) Such process shall serve to continuously monitor the Facility’s compliance with the requirements set forth in these rules. Responsibility for administering and coordinating the quality improvement process shall be delegated to a staff person who has been determined by the Facility to be qualified by education, training, and experience to perform such tasks. The Facility’s medical director shall be actively involved in the process.
- (3) A Facility shall participate in additional quality improvement outcome studies as directed by the SOTA.
Authority: T.C.A. §§ 4-3-1601, 4-4-103, 33-1-302, 33-1-305, 33-1-309, 33-2-301, 33-2-302, and 33-2- 404. Administrative History: Original rule filed September 20, 2012; effective December 19, 2012. Amendments filed June 6, 2025; effective September 4, 2025.